Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ACHV Achieve Life Sciences Inc

4,925

0,035 (0,72%)

27 Jul 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Jul 2023 bis Jul 2024

Click Here for more Achieve Life Sciences Charts.

News Achieve Life Sciences Inc

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
Donnerstag 25 Juli 2024 (2 Tage vor) • GlobeNewswire Inc.

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
Dienstag 9 Juli 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 9 Juli 2024 (3 Wochen vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes
Montag 1 Juli 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 6 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Mittwoch 29 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Montag 20 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 17 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
Freitag 17 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
Donnerstag 9 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Montag 6 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Achieve Life Sciences Inc News-Artikel

Pantheon Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen